Discover how forever chemicals, known as PFAS, represent a pervasive and often underestimated danger to water supplies.

The National Biosecurity Centre will enhance the UK’s detection, surveillance, and control capabilities for high-risk animal diseases.

BioNxt Solutions announces the launch of a feasibility study for the development of an oral dissolvable film (ODF) formulation of Semaglutide, a GLP-1 receptor agonist currently marketed globally under the brand names Ozempic®, Rybelsus®, and Wegovy®.

Learn how miniaturisation is transforming technology by making devices more powerful, efficient, and sustainable.

Discover more about the huge potential of quantum technologies and their commercialisation in the industry.

The STEP programme will receive £2.5 billion over 5 years to lead the global race for fusion energy. Discover more here.

ControlPoint Inc. are committed to developing clinical testing tools that will improve animal health in companion and production animals.

At TRIUMF's particle accelerator laboratory, a new vision for Canadian subatomic physics research and innovation is emerging.

The PFAS treatment plant will remove regulated PFAS compounds from drinking water, fully meeting the EPA's PFAS regulations.

Zeus is unlocking potential hidden beneath the silver-rich terrain of Idaho by tapping into a newly identified copper district.